More focused on the 350 million$
all indications are that they already are closed to or done with the financing. 0 dilution and almost 500 milion in cash on books with approx 200 million more in receivables. This all equates to 3 market cap. If debt = equals to assets then shares should triple. Assets are actually worth around 5 billion$ so there is tremendous upside if cashflows become stable and start growing with new drugs. Could be a 5 bagger from here in a year..buy 1000 shares and hold